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ABSTRACT 
Objective: To compare the analgesic efficacy of Paracervical Block (1% lidocaine) with 
procedural sedation (Midazolam/Fentanyl) in the surgical management of incomplete/ 
missed miscarriages. 
Study design: An efficacy trial with a naturally occurring control group who received what is 
standard practice. The study compared two methods of analgesia. The study group received 
paracervical block and the control group received procedural sedation. The study ran over 
two consecutive months (December 2012/January 2013). 
Setting:  Groote Schuur Hospital, a level three hospital situated in Cape Town, South Africa. 
Population: All women between 18 and 55 years of age that were admitted to Groote 
Schuur Hospital requiring a uterine evacuation following either a spontaneous incomplete 
or  a missed miscarriage that were not excluded by any of the exclusion criteria.  
Methods: Over the two month period recruited participants (those patients who fit the 
inclusion criteria and were agreeable to participate) were allocated to either the control 
group (month 1) or the intervention group (month 2), depending on which month they had 
the uterine evacuation. Data was collected from the uterine evacuations of the recruited 
participants over the two month study period.  
Main outcome measure: The participants perceived pain during and after uterine 
evacuation (10 minutes and two hours), scored by the participant on an eleven point 
numerical pain scale. Secondary outcomes were the surgeons’ satisfaction with the 
analgesia, duration of procedure and complications/ side effects of the two methods of 
analgesia under study. 
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Results:  A total of 111 participants were recruited over the study period, 57 in the control 
group and 54 in the intervention group. The average pain score during the procedure was 
lower in the Paracervical block group compared with the procedural sedation group, but this 
difference was not statistically significant at a 5% level (t=-1.8495, p=0.0671). For the 
Paracervical block group, the ‘’pain during” mean and the standard deviation (SD) were 5.56 
and 2.50 respectively, whilst for the Procedural sedation group, the mean and SD were 6.49 
and 2.81 respectively. 
Conclusion: Paracervical block using 1% lidocaine is an effective and safe alternative to 
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INTRODUCTION AND LITERATURE REVIEW 
The incidence of first trimester pregnancy loss is around 14- 19% of registered pregnancies. 
[1, 2] Therefore it is no surprise that admissions for incomplete and missed miscarriages 
constitute a major proportion of the gynaecology workload of public sector hospitals in 
South Africa. [3] Approximately 50% of early pregnancy losses are caused by chromosomal 
abnormalities. Other causes include infection, reproductive tract abnormalities, exposure to 
toxins, and uncontrolled endocrine or auto immune disease in the mother. Diagnostic 
testing to determine etiology of the loss is limited [4] 
Therapeutic options for incomplete miscarriages include expectant, medical and surgical 
management. [2, 5] Surgical treatment has been the method of choice for years and is 
effective but is not without complications, such as uterine perforation. Medical 
management usually involves the systemic and /or local administration of a prostaglandin 
analogue. [2] The effectiveness of different treatment modalities has been studied by 
several randomized controlled trials. A meta- analysis by Sotiriadis et al concluded that one 
additional successful evacuation is achieved for every three women treated surgically rather 
than medically. [2] A comparative review by Bygdeman et al concluded that both methods 
are equally well accepted provided the patient has the choice. [5] 
There is a vast amount of literature comparing sharp curettage to suction aspiration 
(electrical/manual).  A Cochrane Review by Tuncalp et al shows statistically significant 
decrease in blood loss, intra procedural pain and duration of procedure when using suction 
curettage. [6] A comparative study by Mohamed et al also showed that MVA (manual 
vacuum aspiration) was just as safe as an even more effective in achieving complete uterine 
evacuation than sharp curettage, and therefore has the potential to decrease health costs 
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and improve patient care. [7] Adinma et al concluded that the Karman’s cannula and 
vacuum aspirator ‘is considered to be an invaluable, safe, and efficient tool in routine 
gynaecological practice’. [8] 
Uterine evacuation is associated with varying degrees of pain and requires some form of 
analgesia /anaesthesia. The various methods available are oral non- steroidal anti-
inflammatory drugs (NSAID), local anaesthetic (topical/injectable), intravenous/ inhalation 
procedural sedation and analgesia and general anaesthesia. It is recommended by the 
World Health Organisation (WHO) guideline of 2002 that for uncomplicated evacuations 
general anaesthesia be avoided. This is to decrease its associated morbidity/mortality, 
particularly the loss of airway control. 
In the Western Cape public health sector, procedural sedation and analgesia (PSA) is 
commonly used for uterine evacuations.PSA reduces the discomfort, apprehension, and 
potential unpleasant memories associated with an evacuation. PSA involves the use of short 
acting analgesic and sedative medication thus allowing a clinician to perform the procedure 
effectively. PSA exists along a spectrum, of which some of the commonly used terms are 
listed below. 
 Analgesia – relief of pain without sedation. 
 Minimal sedation – able to respond normally to verbal commands, cognitive function 
and co ordination may be affected. Ventilation and cardiovascular function are not 
affected. 
 Moderate sedation and analgesia- able to respond purposefully to verbal commands 
alone and to light touch. Ventilatory and cardiovascular function is not affected. 
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 Deep sedation and analgesia- patient not aroused easily responds purposefully to 
noxious stimulation. Ventilatory function may be affected. Cardiovascular function is 
unchanged. 
 General anaesthesia- patient is not arousable, requires full ventilatory support. May 
have cardiovascular impairment. 
 Dissociative sedation – is a trance- like cataleptic state. Patient experiences profound 
analgesia and amnesia. Ventilatory and cardiovascular functions remain stable. 
Ketamine causes dissociative sedation. [9] 
 
The most common PSA used, is a combination of midazolam and fentanyl.  Midazolam is a 
short acting benzodiapine that possesses a potent anxiolytic, amnesic, hypnotic, relaxant 
and sedative effect. Some of its side effects are hypotension, respiratory depression and 
impaired cognitive/ psychomotor function. Fentanyl is a potent synthetic analgesic that acts 
at the opioid receptor. It has a rapid onset and a short duration of action. One of the rare 
but more serious side effects is hypoventilation and apnea. Due to the potential side effects 
of the midazolam and fentanyl cocktail, the clinician performing the procedure must be 
skilled in the knowledge about the drugs being used. A recent retrospective case review 
done at a District Hospital in Cape Town demonstrated that PSA can be safely administered 
by  medical officers with no official anaesthesiology training provided they kept to PSA 
guidelines and had knowledge on management of the upper airway. [10] An anaesthetic 
nurse must be present to monitor the patient for any possible side effects, and the 
administration of PSA necessitates a monitored recovery period. [9, 11] 
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For the reasons mentioned above uterine evacuations done under PSA often require the 
procedure to be done in an operating theatre environment. Awaiting theatre space may 
result in unnecessary delays. The following may be a consequence. 
 Increase in pre- procedural blood loss. 
 Increased risk of sepsis due to retained products of conception 
 Increased duration of  inpatient stay 
The end result affects patient care and health care costs adversely. 
 
The study aim was to look at an alternate to PSA, one that could possibly be more efficient 
and safer, (with less systemic side effects) therefore requiring less intra and post-procedural 
monitoring. This study investigated the efficacy and safety of a paracervical block (PCB) 
using lidocaine.  
In 1850 an Austrian named von Scherzer brought an adequate quantum of coca from Peru 
to Europe, which permitted the isolation of cocaine. Sigmund Freud first suggested that 
coca had powerful anaesthetic properties, which led the Austrian, Koller in 1884 to perform 
the 1st operation under local anaesthetic with the administration of cocaine to the eye. The 
toxic effects of cocaine soon became evident, but with the development of modern organic 
chemistry, pure cocaine was synthesized in 1891. Between 1898 and 1972 amino amide 
local anaesthetics including lidocaine became available. [12] 
Local anaesthesia is commonly used in various minor gynaecological procedures. [13] The 
ease and efficiency of the paracervical block makes it a popular choice, especially in an 
outpatient or office setting. [14] It has been shown to be a safe method of anaesthesia for 
hysteroscopy and transcervical surgery. [15] 
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Pain associated with cervical stretching and uterine contraction is transmitted through 
visceral afferent nerve fibres which accompany the sympathetic fibres that pass through 
aggregates of nerve fibres and enter the spinal cord at T11 and T12. These fibres, which are 
adjacent to the cervix, can easily be bathed in local anesthetic solution therefore making 
blockage possible. The transverse cervical ligaments lying just deep to the lateral fornices of 
the vagina are a good landmark. 
The uterine artery and vein and their branches also lie in the lateral fornices. Their close 
proximity to these nerve fibres creates potential for an adverse outcome. Therefore 
meticulous technique needs to be followed to avoid injecting high doses of local anaesthetic 
into these vessels. 
There are many variations with regard to the site of injection. Randomised clinical trials 
have not found differences with respect to the application of the anaesthetic at the 3, 5, 7 
and 9 o’ clock, the 4 and 8 o’ clock positions or circumferential application in the cervix. [16, 
17] 
Local anaesthetic works by reversibly blocking calcium channels in membranes of nerve 
fibres resulting in the inhibition of action potentials and nerve impulse transmission. The 
degree of blockage is dependent on the diameter of the nerve fibre. The smaller the 
diameter, the quicker the onset of the block. The sensory modalities are lost in the following 




4. Deep pressure 
5. Motor function 
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This explains why a patient may have retained motor function with adequate analgesic 
effect. 
Some local anesthetic agents are more lipophilic than others, and therefore are bound to 
receptor sites for longer, resulting in a longer duration of action. Eg. Bupivicaine>lidocaine 
These drugs can be divided into two chemical classes, either Amides or Esters. 
Amides are metabolized in the liver and therefore remain longer in circulation. There is a 
risk of accumulation and toxicity. 
Esters are broken down rapidly in blood; therefore risk of toxicity is less.  A byproduct p-
amino benzoic acid (PABA) can be allergenic. [13] 
This study will use lidocaine 1%, which is an Amide.  Its onset of action is 4 -10 minutes. 
Duration of action is approximately 60 – 120 minutes. Its maximum dose is 4.5mg/kg. 
Adverse effects are few and are largely dose related. Toxicity usually results from repeated 
doses. 
Toxicity with increasing plasma concentration manifests as 
1. Numbness of tongue 
2. Lightheadedness 
3. Auditory and visual hallucinations 




8. Respiratory arrest 
9. CVS depression. 
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There is a vast amount of literature comparing PCB to either placebo or other analgesic and 
anaesthetic agents for uterine evacuation. There are also studies looking at using PCB in 
combination with other agents. 
Two trials comparing PCB with 1% lidocaine to placebo (PCB with either normal saline or 
sterile water) showed a significant decrease in pain during uterine evacuation in the 
lidocaine group. The rationale for using normal saline or sterile water for paracervical 
injection was that the local anaesthetic mechanism may have been from distention of nerve 
capsules rather than blockage of specific autonomic nerves. [18, 19] 
A randomized control trial by Mankowsi et al comparing PCB to an intracervical block 
showed no difference between the two groups, though a possible confounding factor was 
that both groups also received procedural sedation. [20] A prospective trial by Owolabi et al 
looked at PCB with NSAID (diclofenac) and intra-cervical block.  The group receiving all three 
agents was superior to the group using NSAIDS alone. [21]A Cochrane review published in 
2009 titled ‘Paracervical local anaesthesia for cervical dilatation and uterine intervention’ 
compared PCB and other anaesthetic and analgesics agents for women undergoing uterine 
intervention. No difference in effectiveness and safety was found between PCB and other 
anaesthetic and analgesic methods, however PCB using a local anaesthetic agent compared 
to placebo (injection of saline) reduced abdominal pain during uterine intervention 
(endometrial biopsy, fractional curettage, suction evacuation)  by two or three points on a 
ten point scale. [22]There is interesting research looking at PCB in combination with local 
application of lidocaine spray or gel [23, 24] which has shown some benefit. The evidence 
seems to be somewhat conflicting, thus encouraging further investigation of the efficiency 
of PCB. 
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HYPOTHESIS AND AIMS OF THIS INVESTIGATION 
  
Hypothesis  
Paracervical block with 1% lidocaine is an effective alternative analgesia compared to 




The aim of this study was to determine the analgesic efficacy of paracervical block in 
patients undergoing suction curettage for incomplete and missed miscarriages. 
Objectives 
The primary objective of our study was to compare the analgesic efficacy of paracervical 
block with procedural sedation (midazolam/fentanyl) in women requiring uterine 
evacuation for incomplete/missed miscarriage as measured by the patients’ perceived pain. 
Secondary objectives were: 
 Complications and side effects, 
 Surgeon’s satisfaction with analgesia and impact on the procedure. 
 
Study Design  
This was an efficacy trial with a naturally occurring control group who received what is 
current practice. 
We followed a group of patients and tested a new treatment (analgesic option). The 
inclusion criteria consisted of all women requiring surgical management (uterine 
evacuation) following a miscarriage. In two consecutive months patients were allocated to 
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the control group (month 1) and the study group (month 2). Data was collected from all 
recruited participants who had a uterine evacuation in these months at Groote Schuur 
Hospital/ C24 (gynaecology triage area). The objectives, study design and data collection 
were purposefully similar to the Ketamine Trial that was undertaken in C24 for two reasons. 
The first reason was that it was familiar to the staff (doctors/ nurses) collecting the data. 
Secondly there is an interest in analysing and comparing outcomes of the two studies at a 
later stage, with the hope of carrying out a randomized control trial looking at different 
analgesic options for uterine evacuation. 
 
Inclusion criteria 
Patients considered eligible for the study were all women between the ages of 18 and 
55years admitted to GSH for uterine evacuation following                                                           
 a spontaneous incomplete miscarriage 
 a missed miscarriage 
Exclusion criteria 
Patients with the following findings were excluded from the study 
 A ward haemoglobin concentration of 8g/dl or less (done using a Hemocue R 
machine) 
 Signs of sepsis (temperature >37.5, foul smelling vaginal discharge) 
 Evacuation for socio economic motivated termination of pregnancy 
 Any uterine evacuation performed for a patient admitted into the general 
gynaecology wards due to logistic reasons 
Also any women who refused informed consent was not included in the study and received 
standard procedural sedation. 
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Data collection commenced once approval was obtained from the Research Ethics 
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METHODOLOGY 
All patients that were suitable received an information leaflet in English, Afrikaans or Xhosa 
(Addendum 1). The attending doctor explained the outline of the study to the patient and 
consent was obtained. (Addendum 2) 
 The current standard protocol for monitoring of patients undergoing procedural sedation 
for uterine evacuation includes the measurement of blood pressure before and after the 
procedure. The patient’s pulse and oxygen saturation is monitored throughout the 
procedure using pulse oximetry. These basic monitoring measures were continued 
throughout the study duration. Values of blood pressure, maximum pulse and lowest 
oxygen saturation were recorded in the data collection sheet. 
In the first month of data collection (December 2012 – control group) Fentanyl/Midazolam 
was administered. The doses used for procedural sedation were 100mcg Fentanyl and 5mg 
Midazolam administered as an intravenous injection. 
In the second month of data collection (January 2013 – intervention group) all recruited 
patients received paracervical block (PCB). The block was administered by the doctor 
performing the evacuation. This was either a registrar or an intern under supervision. The 
doctor was deemed experienced in administering the block if he/she had previously 
performed a minimum of five PCB as a qualified doctor. If the attending doctor did not fulfill 
this criteria then the Principal Investigator (Dr M Naiker, who had performed approximately 
40 PCB previously) demonstrated the block to the attending doctor and supervised him/her 
for the first five PCB performed.  
Procedure for Paracervical Block: With the patient in the lithotomy position, a cuscos 
speculum was inserted into the vagina so that the cervix could be visualized in its entirety. 
Any blood or pieces of retained products of conception that was obscuring vision, was 
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gently wiped away. Then the 4 o’clock and 8 o’clock positions at the junction of the cervix 
and the vaginal fornices were identified. A 10ml syringe was used to draw up 10mls of 1 % 
(100mg) lidocaine solution. A 22 gauge needle(or a black spinal needle) connected to the 
syringe was then injected into the sites mentioned above to the depth of 3mm- 7mm, 
drawing back first to ensure that the needle was not in a vessel. Then 5mls of the 1% 
lidocaine was injected into each site. A chart with step by step instructions on how to 
administer the block was put up in C24 to serve as a reminder (Addendum 3).Once the block 
was given the clinician removed the cuscos speculum and waited approximately 5 minutes 
before the uterine evacuation was commenced. 
Routine uterine evacuation involved the bladder being emptied with an in and out catheter. 
Then a bimanual examination was performed to determine the uterus size and position. An 
Auvard speculum was inserted into the vagina, so that that the cervix could be visualized. 
The anterior lip of the cervix was grasped with a sponge holding forceps and any products of 
conception at the cervical os were removed with an ovum or polyp forceps. The ovum or 
polyp forceps was introduced into the uterine cavity to remove remaining tissue. At this 
point an oxytocin infusion (20 units of oxytocin in one liter of normal saline over 2-4 hours) 
was commenced if found necessary.  
Evacuation was completed by either sharp curettage or suction aspiration (wall suction at – 
50mmHg or manual vacuum aspiration) with the largest Karman cannula that could pass 
through the cervix. If severe blood loss occurred it was managed with rubbing up the uterus 
and by giving oxytocin (intravenous infusion) or misoprostol (600mcg per rectum). The 
procedure was completed once all retained products of conception were removed and the 
uterus contracted. This was detected clinically when no more products were seen coming 
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through the cannula, a gritty feel was felt when the cannula moved against the 
endometrium and the uterus contracted down. 
 When pain relief was thought to be inadequate to the point at which the procedure was 
unable to continue, the surgeon then administered extra analgesia, being either 5mg 
midazolam, 100mcg fentanyl or both. 
During the procedure the attending nurse asked the patient to score her perceived pain on 
an 11 point numerical rating scale (0-10) (Addendum4). The pain score was repeated at 10 
minutes post procedure by the nurse in recovery and then at 2 hours. 
Other data recorded on the data collection sheet included: 
 time interval from PCB to procedure starting 
 length of procedure 
 ease of procedure 
 surgeons’ satisfaction  with the anaesthetic/ analgesia (patient’s co- operation) 
 estimated blood loss 
 need for additional analgesia over the primary agent 
 any adverse effects 
 
Safety considerations 
Uterine evacuations of stable patients at Groote Schuur Hospital occur in the gynaecology 
triage suite (ward C 24). There is a specially allocated theatre and scrub area in C24 for the 
main purpose of uterine evacuations and other minor gynaecological procedures. Medical 
staff that where present were the surgeon (registrar), trained theatre sister and a nurse. 
Blood pressure and pulse were checked prior to the administration of the 
anaesthetic/analgesia. The patient was monitored throughout the procedure with pulse 
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oximetry. Monitoring was continued in the recovery /post procedure short stay area (also in 
C 24) for about 15 minutes. The patient was then observed for about 6 -8 hours post 
evacuation and if stable was subsequently discharged. C24 is equipped with a 
cardiovascular/ respiratory emergency trolley. In the case of a cardiovascular/ respiratory 
arrest there was always either an emergency medicine registrar (in C15) and/or an 
anaesthetist from main theatre (D16) that could have been requested to assist in 
resuscitation. All medical staff in C24 was informed of the possible side effects of 
paracervical block with special mention of the fact that most adverse effects are dose 
related. Staff training sessions/ briefings were given, as well information sheets. 
 
Patient follow up 
The patient was reviewed and assessed before discharge as is routine practice (either by 
registrar or intern). That included checking the vital signs (blood pressure, pulse and 
temperature), haemoglobin and vaginal bleeding. If the patient was deemed fit for 
discharge she was informed that if bleeding continued or if she developed a fever or a foul 
smelling vaginal discharge, she was to return to hospital. All patients with pregnancy related 
complications had their blood grouping done and were screened for syphilis and treated 
accordingly. Routine discharge medication for patients post evacuation were simple 
analgesia (paracetamol/ibuprofen), oral antibiotics (metronidazole and doxycycline) if 
indicated, and iron supplements if their haemoglobin was less than 10g/dl. Family planning 
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Data Management and Statistical Analysis 
Data collection sheets and participant information leaflets with consent forms were readily 
available in C 24. The study was outlined by the attending doctor to the possible participant 
(recruited patient). Consent was obtained once a participant had read through the 
participant information leaflet and was agreeable to participate. The Participant Information 
Leaflet was then separated from the consent form and given to the participant to take 
home. The Data Collection Sheet was then placed into the participant’s hospital folder and 
was available at time of uterine evacuation. Data was collected by a sister/doctor and was 
entered into the Data Collection Sheet.  At discharge the Data Collection Sheet was handed 
to the Principal Investigator, who then captured the data. 
The participant’s Data Sheet included a random ‘study ID number’. The participants name, 
hospital number and corresponding study ID number was recorded on the participant’s 
consent form. The Principal Investigator had sole access to this information and it was kept 
in a secure location to ensure patient confidentiality. Data was entered into an Excel 
spreadsheet on a password protected computer. The original paper data was filed and kept 
in a secure location, only accessible to the Principal Investigator. 
Data was analyzed using standard statistical techniques. Categorical data were compared 
using odds ratio with a 95% confidence interval. Continuous variables were analyzed using 
the t test if normally distributed and with the Wilcoxon rank sum test if data was skewed. A 
P – value of less than 0.05 was regarded as ‘statistically significant’. 
Sample sizes were expected to be approximately 50 to 80 patients per group. This was 
estimated from the average number of uterine evacuations performed in patients over the 
age of 18 years using procedural sedation over 6 month duration at Groote Schuur Hospital 
(C24). 




September 2012               : Protocol handed into the Research Ethics Committee of the  
                                               Faculty of Health Sciences of the University of Cape Town. 
November 2012                : Ethics approved 
December 2012                : Control group data collected 
January 2013                    : Study group data collected 
February 2013                  : Statistical analysis 
March 2013                      : Write up and completion of dissertation                    
 
Anticipated problems 
We anticipated an adequate number of patients willing to participate. The 2 hour pain score 
was anticipated to be a problem, for the staff may be occupied with other work. Thus this 
follow up was allowed the leeway of happening between 120- 180 minutes post procedure. 
 
Ethics 
Ethical approval for the study was granted from the Research Ethics Committee of the 
Faculty of Health Sciences of the University of Cape Town. HREC NO: 521/2012 
Enrolment was on a voluntary basis. The participant gave written consent once she had read 
through the Participant Information Leaflet (the procedure and study explained in lay terms) 
and had agreed to participate. The surgeon/ investigator also signed the consent stating 
that he/she had adequately outlined the study and that the participant understood the 
information given. The consent included one witness. 
 




The costs of the study were the responsibility of the Principal Investigator, Dr Manasri 
Naiker. The UCT Department of Obstetrics and Gynaecology will be approached with 
possible assistance/reimbursement from the Registrars Research Fund. 
 
Dissemination of results 
The data collected will be presented at relevant seminars and scientific meetings. We hope 
to carry out a large randomised controlled trial comparing different methods of analgesia 
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RESULTS 
Over the two month study period a total of 212 uterine evacuations were performed in C24.  
111 (52%) participants were recruited and 101 (48%) were not. Of the 101 patients that 
were not recruited, 40 (39.6%) patients declined participation and 61 (60.4%) were excluded 
according to the exclusion criteria. 
 













Of total number of 111 participants were recruited, there were 57 participants in the control 








Declined=40                            Excluded=61 
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Table 1: Depicts participants per group.  
GROUP FREQUENCY PERCENTAGE 
PARACERVICAL BLOCK  
                54   48.65 
PROCEDURAL 
SEDATION 
 57 51.35 
TOTAL 111 100 
 
There were 72 incomplete miscarriages and 39 missed miscarriages in total over both 
groups:   
Table 2: Depicts different types of miscarriages 
TYPE FREQUENCY PERCENTAGE 
INCOMPLETE  72 64.86 
MISSED 39 35.14 
TOTAL 111 100 
 
All participants who had a missed miscarriage received pre procedural vaginal misoprostol 
for cervical ripening (600mcg), and 2 participants who had an incomplete miscarriage 
received misoprostol (600mcg). Only 8 of the total number of participants required cervical 
dilatation before uterine evacuation and all 8 of these participants had a missed 
miscarriage.  
There were 87 participants that had a 1st trimester miscarriage and 24 participants that had 
a 2nd trimester miscarriage.  
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Figure 2: Percentage of 1st and 2nd trimester miscarriages of total recruited participants. 
 
 
Surgeon performing procedure 
Most uterine evacuations were performed by registrars. Only 16 out of the total 111 uterine 
evacuations were performed by interns, of those 6 and 10 were in the PCB and the 
procedural sedation groups respectively, with an OR 0.587 [95% CI 0.198-1.740]. This finding 
is not statistically significant. 
 




















paracervical block procedural sedation
Intern
Registrar




 Most procedures were less than ten minutes. There were 35 and 42 uterine evacuations 
that took less than ten minutes in the PCB and procedural sedation group respectively and 
17 and 12 uterine evacuations were between 10 -15 minutes respectively. The number of 
uterine evacuations that were longer than 15 minutes duration was 2 in the PCB group and 
3 in the procedural sedation group. OR 0.692 [95% CI 0.111-4.309]. This finding is not 
statistically significant. 
 




Seven of the uterine evacuations in the PCB group were difficult to perform compared the 3 
in the procedural sedation group, with an OR 2.680 [95% CI O.680-10.560]. This finding was 
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Severe blood loss was documented in 3 uterine evacuations in the PCB group and none in 
the procedural sedation group. 
Figure 6: Estimated blood loss across the groups.
 
 
Unco- operative patients 
There were 8 (7.21%) participants in total that were uncooperative. Of the 8 participants, 7 
required extra analgesia. Of the 7 participants requiring extra analgesia, 4 (57%) got an extra 
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got both. Four of these participants were in the PCB group and 3 were in the procedural 
sedation group. OR 1.44 [95% CI 0.307-6.754]. This finding was not statistically significant. 
 
Figure 7: Percentage of participants requiring extra analgesia across both groups. 
 
 
Figure8: Frequency of the type of extra analgesia used in each group. 
 
 
101 (90.9%) of participants had a suction curettage compared to 10 (9.01%) participants 
that had a sharp curettage.  








paracervical block procedural sedation
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There was no significant difference in the mean “pain during” value between the 2 groups 
(at a 5% level): t=-1.8495, p=0.0671. For the PCB group, the ‘’pain during ” mean and the 
standard deviation (SD) were 5.56 and 2.50 respectively, whilst for the Procedural sedation 
group, the mean and SD were 6.49 and 2.81 respectively, ie the average “pain during ” value 
was higher in then Procedural sedation group. There was no significant difference in the 
median or IQR between the 2 groups at the 10 minute and 2 hour pain scores. 
 
Table 3: Pain scores at different time intervals between groups 








PAINDURING 54 0 9 5.56 2.50 6 4 8 
PAIN10MIN 54 0 9 1.57 2.25 0 0 3 
PAIN2HOURS 53 0 3 0.21 0.63 0 0 0 
PROCEDURAL SEDATION 
PAINDURING 57 0 10 6.49 2.81 7 5 9 
PAIN10MIN 57 0 6 1.63 2.02 0 0 3 
PAIN2HOURS 57 0 3 0.37 0.84 0 0 0 
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 Figure 9: The box plot below shows the median value, the IQR, and the minimum and 
maximum values for ‘’pain during ’’ for the 2 groups.
 
 
When we compared pain scores between those participants who had a uterine evacuation 
for either an incomplete miscarriage or a missed miscarriage, we found no significant 
difference in the mean or SD for the pain experienced during the procedure for either of the 
two types of miscarriages. There was no significant difference at the 10 minute or 2 hour 
pain score either. We further analysed the mean pain score during the procedure for each 
group (paracervical block and procedural sedation) within the different type of miscarriages 
(incomplete and missed miscarriages) and found no significant difference. 
 
 Similarly no significant difference was found when we compared pain scores at the 
different time intervals in those participants who had a 1st trimester and 2nd trimester 
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procedure for each group (paracervical block and procedural sedation) for the different 
trimesters. 
 









The difference in the mean pain scores during the procedure between the 2 groups was 
insignificant for those participants having an incomplete miscarriage, ie 
 -1.107 with the p value =0.659 and confidence interval of -2.423 to 0.209. 
 








PAINDURING 72 0 10 5.90 2.87 6 4 8 
PAIN10MIN 72 0 9 1.54 2.10 0 0 3 
PAIN2HOURS 71 0 3 0.25 0.65 0 0 0 
MISSED MISCARRIAGE 
PAINDURING 39 2 10 6.28 2.34 7 5 8 
PAIN10MIN 39 0 7 1.72 2.19 0 0 3 
PAIN2HOURS 39 0 3 0.36 0.90 0 0 0 




PAIN  SCORE DURING  33 5.303 2.506 
PROCEDURAL 
SEDATION 
PAIN  SCORE DURING  39 6.410 3.092 
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The difference in the mean pain scores during the procedure between the 2 groups were 
insignificant  for those participants having a missed miscarriage, ie -0.714 with a p value of 
0.743 and a confidence interval of -2.220 to 0.791. 
 











PAIN SCORE DURING  21 5.952 2.499 
PROCEDURAL  
SEDATION 
PAIN SCORE DURING  18 6.666 2.142 








PAINDURING 87 0 10 6.06 2.83 6 4 8 
PAIN10MIN 87 0 9 1.62 2.27 0 0 3 
PAIN2HOURS 86 0 3 0.28 0.76 0 0 0 
SECOND TRIMESTER 
PAINDURING 24 2 10 5.96 2.18 5.5 5 7 
PAIN10MIN 24 0 5 1.54 1.53 1.5 0 2.5 
PAIN2HOURS 24 0 2 0.33 0.70 0 0 0 
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The difference in the mean pain scores during the procedure between the 2 groups were 
insignificant for those participants having a 1st trimester miscarriage, ie -0.803 with a p 
value =0.603 and a confidence interval of -2.003 to 0.396. 
 





The difference in the mean pain scores during the procedure between the 2 groups were 
insignificant for those participants having a 2nd trimester miscarriage, ie -1.433 with a p 













PAIN SCORE DURING   43 5.651 2.715 
PROCEDURAL 
SEDATION 
PAIN SCORE DURING   44 6.454 2.913 




PAIN SCORE DURING  11 5.181 1.401 
PROCEDURAL 
SEDATION 
PAIN SCORE DURING  13 6.615 2.534 
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When pre operative blood pressure, post operative blood pressure, lowest oxygen 
saturation and highest pulse were compared across both groups, there was no significant 
difference seen in any of the variables. 
 Table 10: Pre/ post operative blood pressures, lowest oxygen saturation and highest pulse 














PRESBP 54 86 220 123.57 21.85 118.5 110 133 
PREDBP 54 40 122 67.96 15.01 69 58 77 
POSTSBP 54 84 222 118.59 21.81 118 105 128 
POSTDBP 54 44 150 69.57 17.70 67.5 59 76 
LOW O2 54 72 100 96.31 5.66 98 96 100 
H PULSE 54 61 152 91.22 18.62 89.5 80 95 
PROCEDURAL SEDATION 
PRESBP 57 89 192 119.67 19.87 118 104 129 
PREDBP 57 40 100 63.68 12.03 63 54 73 
POSTSBP 57 79 153 119.46 16.78 118 109 128 
POSTDBP 57 40 101 67.42 12.02 68 61 73 
LOW O2 57 75 100 96.25 4.69 98 95 99 
H PULSE          57               67              138     93.07       15.21             91                        82                      100 
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DISCUSSION 
Procedural sedation is a highly effective and safe method of analgesia for uterine evacuation 
when used correctly as recommended by the World Health Organisation. 
Paracervical block is an effective alternate analgesia for women requiring a uterine 
evacuation for the management of incomplete/missed miscarriages, with pain scores 
comparable to that experienced with procedural sedation. 
Approximately eighty percent of miscarriages were 1st trimester and twenty percent were 
2nd trimester. About two thirds were incomplete miscarriages and one third missed 
miscarriages. The trimester and type of miscarriage did not have an effect on pain 
experienced. One would have expected the participants who had a 2nd trimester miscarriage 
to experience more pain since they had a larger sized uterus. A difference may have been 
demonstrated if sample sizes were larger. It was not surprising to find no significant 
difference in pain scores between the participants who had an incomplete and missed 
miscarriage since all participants who had a missed miscarriage received pre procedural 
misoprostol for cervical ripening. This reduced the number of participants needing cervical 
dilatation to a minimum and subsequently the pain experienced with cervical stretching 
during dilatation. 
PCB is as safe as procedural sedation. As seen in the study were no adverse effects were 
witnessed in both groups and were prolonged procedure length was less likely in the PCB 
group.  
 The reason for the 3 participants in the PCB group experiencing severe blood loss compared 
with none in the procedural sedation group is not well understood. It could possibly due to 
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an increase in duration and difficulty of those specific uterine evacuations, but only 1 of 
those 3 participants had a procedure length > 15 minutes together with difficulty being 
documented. The other 2 were easy to perform and took < 15 minutes. In addition we have 
already demonstrated that it was less likely to have a prolonged uterine evacuation in the 
PCB group. The only plausible cause is that the severe blood loss was attributed to the 
participants’ specific clinical presentation (example: exact gestational age and amount of 
retained products), information which was not recorded on the data collection sheet. 
 The frequency of difficult procedure and need for extra analgesia were higher in the 
paracervical group. It was interesting to find that extra analgesia was needed in the 
paracervical block group since we demonstrated similar (slightly lower) mean and SD for 
intra procedural pain scores. Extra analgesia was more likely given for increased levels of 
restlessness and anxiety where the sedation effects of midazolam and/or fentanyl were 
required. 
Interestingly the 10 sharp curettages done were all done by the same clinician, showing 
operator preference. This clinician was reminded of the strong clinical evidence favoring 
suction over sharp curettage. 
We were surprised to have found no difference in the lowest oxygen saturation between 
the two groups. The lowest oxygen saturation ranged from 75% to 100% and 72% to 100% 
in the control group and the intervention group respectively.  We had expected a lower 
average value in the procedural sedation group since we know that benzodiapines cause 
respiratory depression. On retrospective enquiry, it was found that the C24 staff 
prophylactically (before a drop in oxygen saturation) and throughout the procedure 
administered 40% face mask oxygen to all participants in the procedural sedation group. 
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This was done because of past experience; patients who received procedural sedation 
almost always had a significant drop in oxygen saturation.  This was not done in the PCB 
group. We believe a significant drop in oxygen saturation may have been demonstrated in 
the procedural sedation group if oxygen was not given prophylactically, but only when 
needed. The lack of demonstrating this information was an oversight in methodology. 
However it would have been difficult to stop giving prophylactic oxygen since this is 
standard practice in the facility. 
The highest pulse rate was recorded for each patient. In the intervention group the results 
ranged from 61/min to 152/min. In the control group the highest pulse rate ranged from 
67/min to 138/min. 
The time differences from the administration of the analgesia to the time of the start of the 
procedure were not analysed because the time intervals in both groups were minimal and 
thought not to affect the main outcome of the study. The mean time difference in the 
paracervical block group was 05.33 mins. The mean time difference in the procedural 
sedation group was 05.22mins. 
 
Limitations 
We were unable to determine the exact time of discharge of the participants due to logistic 
issues. Firstly a minimum of 6 hrs post procedure stay is standard protocol for any patient 
having uterine evacuation. Secondly numerous staff members and 12 hourly nursing shifts 
resulted in a break in communication when it came to documenting the time of discharge 
on the data sheets. Lastly a large proportion of the participants used public transport and 
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therefore those who had their uterine evacuations after 16:00 waited until the following 
morning before they were formally discharged. The general opinion from the C 24 staff was 
that the participants in the paracervical group where mobile, eating and drinking and fit to 
go home earlier in comparison to those participants in the procedural sedation group. This 
can be explained by the fact that Paracervical block has no sedation effects. Further studies 
documenting the exact time of discharge and post procedural vital checks are required to 
confirm these findings. 
Patient demographics, socio economic status, history (previous gynaecological history 
especially) and details on clinical presentation (gestational age and amount of retained 
production of conception) are all factors that could affect the participants perceived pain 
and were not explored. 
Due to time and practical constraints it was decided not to include nurse and doctor 
experiences. However this information was volunteered informally and will be a meaningful 
inclusion in future studies of this nature.  An interesting point volunteered was that most 
patients who refused to participate did so because of the fear of an injection into their 
cervix or/and that they preferred to be sleepy and unaware (sedated) during the procedure.  
This suggests possible bias and refusal of participant to be in the study was the perceived 
pain which may have been felt when PCB was done.  Low dose midazolam (1mg ivi) prior to 
administering the PCB is definitely a consideration for future investigation. 
Possible bias that could have influenced pain scores was proficiency bias, since fewer 
uterine evacuations in the PCB group were performed by interns. The main reason for this 
was that registrars were more experienced in administrating the PCB.  Performance bias 
could have also taken place, since participants were aware of which group they were 
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allocated to and this could have heightened their perceived pain. This could be overcome by 
blinding the participant and the nurse recording the pain score. 
Paracervical block with 1% lidocaine provided comparable pain relief when compared to 
procedural sedation with midazolam/fentanyl for the surgical management of incomplete 
and missed miscarriages. This data suggests that a multi centre, randomised, double blind 
trial should be undertaken. There are distinct advantages to exploring alternatives to 
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ADDENDA 
1. Participant Information leaflet 
2. Consent 
3. Paracervical block- Step by Step instruction 
4. Verbal Pain Score 
5. Data Collection Sheet 
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A STUDY COMPARING THE EFFICACY OF PARACEVICAL BLOCK TO PROCEDURAL    
SEDATION IN THE SURGICAL MANAGEMENT OF INCOMPLETE/MISSED MISCARRIAGES. 
HREC NO: 521/2012 
Participant Information Leaflet 
We are inviting you to take part in our study/investigation that looks at different ways to 
provide pain relief during the treatment of a miscarriage. The following are answers to your 
possible questions. If any of your questions are not answered, please feel free to ask the 
doctor who is attending to you. 
What is a miscarriage? 
A miscarriage is when a pregnancy fails to progress beyond 24 weeks (the first two thirds of 
the pregnancy). It is called a miscarriage when the fetus (baby growing inside the womb) is 
500g or less. Often we do not know the exact cause of miscarriages, but we do know it is 
common. We also know that many women go on to have a successful outcome (live baby) in 
following pregnancies. Most miscarriages cause vaginal bleeding because the mouth of the 
womb starts to open up. Part of the womb is made up of muscle which contracts (squeezes) 
during a miscarriage to try and push out the fetus and placenta. Therefore you may get 
lower abdominal/stomach pain. If the fetus and the whole placenta are pushed out we call 
this a complete miscarriage. When some products of pregnancy (fetus and placenta) are still 
in the womb, we then call that an incomplete miscarriage. Sometimes all the products of 
pregnancy are still in the womb, but the fetus has no heartbeat and the mouth of the womb 
is closed, we call this a missed miscarriage. The heartbeat of the fetus can first be seen by 
47 | P a g e  
 
the doctor using the ultrasound scanning machine (a special machine that allows us to see 
inside the womb) at 6 – 8 weeks (1 ½ - 2 months) of the pregnancy.  
If a patient has a missed or incomplete miscarriage they will need the doctor to remove the 
products of pregnancy, to stop the bleeding, and to make sure they don’t become ill with an 
infection (pain and fever). If the mouth of the womb is opened and there are still products 
of pregnancy inside it may allow infection to enter and grow which can make a patient very 
sick. 
How does the doctor remove the pregnancy products? 
There are 3 choices.   
1. Wait for the products to come out on their own. This can lead to the problems of 
bleeding and infection mentioned above and may require you to come in and out of 
hospital many times.  
2. The doctor can give you medication which will help the mouth of the womb to open 
and makes the womb muscle contract/squeeze stronger. Once again the problem of 
bleeding and infection may occur.  
3. The doctor can do a womb scrape/suction (uterine evacuation). This method does 
not require you to follow up, unless a problem arises.  A small plastic pipe which has 
an opening at either end is used. The plastic pipe is connected to a suction system 
and the products of pregnancy are removed. The womb scrape is often very quick. 
Usually it takes about 10-15 minutes.  All the equipment used is specially cleaned 
(sterile) to decrease your chance of getting an infection. Once the womb scrape is 
done and you are well, there is no need for you to return to the doctor.  If needed 
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you may get a course of antibiotics to take home with you to prevent you from 
getting an infection.  
 
What pain relief medication do I get? 
This question brings us to the study we are doing. We are trying to find out if there is 
better medication than the one we are currently using. We are currently using two 
medications; Midazolam and Fentanyl. They are in liquid form and are given directly into 
the blood stream using a drip. These medications make you relaxed and drowsy. They 
are also strong painkillers. They can sometimes make you forget exactly what happened. 
You will feel drowsy for a while after the womb scrape. 
The pain relief medication that we are looking at for our study is called a paracervical 
block.  What this means is that we use a numbing medication (local anaesthetic -
lidocaine), and inject it around the nerves found near the mouth of the womb. These 
nerves are fibres that allow us to feel pain. If we numb these nerves, we hope to numb 
the pain. The paracervical block has been used before for womb scrapings and has been 
shown to be a good painkiller but we want to find out more information on it, especially 
focusing on our community and patients. When we use the paracervical block, you will 
not feel sleepy or drowsy. 
If I agree, which medication do I get? 
It depends on which month you have the procedure. The doctor will inform you which 
medication is being used. 
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Am I helping? 
Yes. If you agree, you are helping our investigation. The more patients we have in our 
study, the better the information we obtain. We hope that in the future this information 
will help other patients that need a womb scrape. 
Do I get paid? 
No, unfortunately you don’t get paid. 
Is it harmful? 
No. All these medications have been tested and used in clinical practice many times 
previously and we know that they are safe when used properly. All our doctors are 
properly trained and can intervene if anything should go wrong. 
If I agree, what must I do? 
You will be asked to rate/ score your pain on a number scale, with 0 being no pain and 
10 being the worst pain you have felt. This will happen once during the womb scrape 
and twice afterwards. 
Will my name be kept a secret? 
There is a record of all patients seen in C24 (gynaecology emergency room) and the 
doctors will make notes as usual. The information about your experience with the pain 
relief medication will be used, but you will be given a number, so that your name will be 
a secret. Only the principal investigator of the study will know which number is yours. 
The principal investigator cannot let anyone else know this information. So yes, your 
name will be kept secret.  
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If I don’t agree, what will happen? 
You will receive the current pain relief medication (Midazolam/Fentanyl) that is being 
used. 
If anything goes wrong who do I contact? 
Below are the names and telephone numbers of the doctors involved in the study.  
Principal Investigator 
Dr M Naiker 
Registrar 
UCT Department of Obstetrics and Gynaecology 
Tel: 021 402 6464/ cell: 0824139244 
 
Supervisors: 
Dr GA Petro 
Chief Specialist and Head of Obstetrics and Gynaecology Metro West 
New Somerset Hospital, Green point 
Tel: 021 402 6324 
 
Dr A Reed 
Chief Specialist Anaesthesiologist 
Metro West Anaesthetic service 
New Somerset Hospital, Green point 
Tel: 0214026418 
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Contact details of doctor not involved in study: 
Dr P Archary 
Registrar 
UCT Department of Obstetrics and Gynaecology 
Tel: 021 4043536/ 021 4046020 
 
Chairman of the Research Ethics Committee of the Faculty of Health Sciences of UCT: 
Assoc/Prof M Blockman 
Division of Pharmacology, Dept of Medicine 
K floor, old main building, GSH 
Tel: 021 4066496 
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A  STUDY COMPARING THE EFFICACY OF PARACERVICAL BLOCK TO PROCEDURAL 
SEDATION IN THE SURGICAL MANAGEMENT OF INCOMPLETE/MISSED MISCARRIAGES. 
HREC NO: 521/2012 
CONSENT FORM 
I have read the participant information leaflet, or it has been read to me. I have had the 
opportunity to ask questions about the study and any questions that I have asked have been 
answered to my satisfaction. I understand that paracervical block may be given for pain 
relief for uterine evacuation. 
I understand that clinical data will be collected for research purposes. Confidentiality will be 
maintained and I will not be identifiable. 
I agree to take part in this research study and understand that my participation is entirely 
voluntary and I may withdraw at any time. Declining to participate will not affect my 
medical care. The study poses no risk to me. I understand that I may not benefit directly 
from study. 
I have been given the contact details of persons who are involved in the study and who I 
may contact to answer questions, if I so choose. I will be provided with a copy of the 
informed consent form. 
 PARTICIPANT’S NAME                                    SIGNATURE 
___________________                                  _________________ 
INVESTIGATOR’S NAME                                   SIGNATURE 
___________________                                  _________________ 
WITNESS’S NAME                                             SIGNATURE 
__________________                                     _________________ 
DATE ____/____/____ 
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ADMINISTRATION OF A PARACERVICAL BLOCK 
 
THE PATIENT IS CLEANED AND DRAPED IN LITHOTOMY 
 
A SPECULUM IS PASSED TO VISUALISE THE CERVIX 
 
GRASP THE ANTERIOR LIP OF THE CERVIX WITH A VELSELLUM, 
TO GENTLY MANIPULATE THE CERVIX. 
 
THE 4 0’ CLOCK AND 8 0’ CLOCK POSITION ON THE CERVIX MUST 




5MLS OF LIDOCAINE IS INJECTED INTO THESE 2 SITES, AT A 
DEPTH OF 3-7mm ON THE CERVIX. REMEMBER TO DRAW BACK 
BEFORE INJECTING TO ENSURE THAT ONE IS NOT IN A VESSEL. 
 
WAIT 5 MINUTES TO ALLOW BLOCK TO WORK. 
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A STUDY COMPARING THE EFFICACY OF PARACERVICAL BLOCK TO PROCEDURAL 
SEDATION IN THE SURGICAL MANAGEMENT OF INCOMPLETE MISCARRIAGES 
DATA COLLECTION FORM – ANALGESIA FOR EVACUATIONS 
 
STUDY ID      DATE: 
 
 
TYPE OF ABORTION:          SPONTANEOUS INCOMPLETE  /   MISSED 
TRIMESTER:                 1ST       2ND 
 
SURGEON:    INTERN/MEDICAL OFFICER  REGISTRAR 
PATIENT WEIGHT:    ________KG 
 
PRE –OP MISPROSTOL  
PRIMARY MEDICATION AND DOSE  
FENTANYL  _________MCG 
   MIDAZOLAM  _________MG 
     LIDOCAINE           _________ %/MLS 
 
TIME OF ADMINISTRATION:  ____H____ 
 
TIME OF START OF SURGERY: ____H____ 
 
VITAL SIGNS: PRE-OP BP _____/_____ 
 POST-OP BP _____/_____ 
 HIGHEST PULSE _________ 
 LOWEST O2 SAT _________ 
 
SURGERY: CERVICAL DILATATION NECESSARY YES  NO   
  
LENGTH OF PROCEDURE  <10MIN  10-15MIN >15MIN 
  
EASE OF PROCEDURE EASY DIFFICULT 
 
 BLOOD LOSS MILD MODERATE SEVERE  
 
 CURETTAGE SUCTION SHARP   
  
SATISFACTION WITH ANALGESIA  
 WAS PT CO-OPERATIVE YES  NO 
 COMPLETENESS OF PROCEDURE YES  NO 
 NEED FOR ADDITIONAL ANALGESIA YES  NO 
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PAIN SCORES 
Using the 10 point Pain Scale depicted below, score patients 
pain perceived at the following times. 
 
 DURING EVACUATION 
 
 1O MINUTES AFTER EVACUATION 
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Table 1: Depicts percentage of participants per group.  
GROUP FREQUENCY PERCENTAGE 
PARACERVICAL BLOCK  
               54     48.65 
PROCEDURAL 
SEDATION 
 57 51.35 













EXCLUDED=61 DECLINED=40                            
Post TOP = 47 
LOW HB =7 
SEPSIS =3 
AGE =4 
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Table 2: Percentage of different types of miscarriages 
TYPE FREQUENCY PERCENTAGE 
INCOMPLETE  72 64.86 
MISSED 39 35.14 
TOTAL 111 100 
 
 
Figure 2: Percentage of 1st and 2nd trimester of total recruited participants. 
 
 




















paracervical block procedural sedation
Intern
Registrar
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Figure 4: Frequency of procedure length between groups. 
 
Figure 5: Ease of procedure between groups. 
 
 





































60 | P a g e  
 
Figure 7: Percentage of participants requiring extra analgesia across both groups. 
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Table 3: Pain at different time intervals between groups. 
 
 
 Figure 9: box plot shows the median value, the IQR, and the minimum and maximum values 





































PAINDURING 54 0 9 5.56 2.50 6 4 8 
PAIN10MIN 54 0 9 1.57 2.25 0 0 3 
PAIN2HOURS 53 0 3 0.21 0.63 0 0 0 
PROCEDURAL SEDATION 
PAINDURING 57 0 10 6.49 2.81 7 5 9 
PAIN10MIN 57 0 6 1.63 2.02 0 0 3 
PAIN2HOURS 57 0 3 0.37 0.84 0 0 0 
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Table 4: Pain scores at the different time intervals in an incomplete and missed miscarriage. 
 
 




















PAINDURING 72 0 10 5.90 2.87 6 4 8 
PAIN10MIN 72 0 9 1.54 2.10 0 0 3 
PAIN2HOURS 71 0 3 0.25 0.65 0 0 0 
MISSED 
PAINDURING 39 2 10 6.28 2.34 7 5 8 
PAIN10MIN 39 0 7 1.72 2.19 0 0 3 
PAIN2HOURS 39 0 3 0.36 0.90 0 0 0 




PAIN  SCORE DURING  33 5.303 2.506 
PROCEDURAL 
SEDATION 
PAIN  SCORE DURING  39 6.410 3.092 




PAIN SCORE DURING  21 5.952 2.499 
PROCEDURAL  
SEDATION 
PAIN SCORE DURING  18 6.666 2.142 
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Table 7: Pain scores at different time intervals in first and second trimester miscarriages. 
 




















PAINDURING 87 0 10 6.06 2.83 6 4 8 
PAIN10MIN 87 0 9 1.62 2.27 0 0 3 
PAIN2HOURS 86 0 3 0.28 0.76 0 0 0 
SECOND TRIMESTER 
PAINDURING 24 2 10 5.96 2.18 5.5 5 7 
PAIN10MIN 24 0 5 1.54 1.53 1.5 0 2.5 
PAIN2HOURS 24 0 2 0.33 0.70 0 0 0 




PAIN SCORE DURING   43 5.651 2.715 
PROCEDURAL 
SEDATION 
PAIN SCORE DURING   44 6.454 2.913 




PAIN SCORE DURING  11 5.181 1.401 
PROCEDURAL 
SEDATION 
PAIN SCORE DURING  13 6.615 2.534 
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PRESBP 54 86 220 123.57 21.85 118.5 110 133 
PREDBP 54 40 122 67.96 15.01 69 58 77 
         POSTSBP 54 84 222 118.59 21.81 118 105 128
POSTDBP 54 44 150 69.57 17.70 67.5 59 76 
LOW O2 54 72 100 96.31 5.66 98 96 100 
H PULSE 54 61 152 91.22 18.62 89.5 80 95 
PROCEDURAL SEDATION 
PRESBP 57 89 192 119.67 19.87 118 104 129 
PREDBP 57 40 100 63.68 12.03 63 54 73 
POSTSBP 57 79 153 119.46 16.78 118 109 128 
POSTDBP 57 40 101 67.42 12.02 68 61 73 
LOW O2 57 75 100 96.25 4.69 98 95 99 
H PULSE          57               67            138       93.07            15.21            91                     82                      100 
